FBN1 and Alzheimer disease: Heterozygous mutations located in exons 41 and 42 encoding the transforming growth factor (TGF)-β-binding protein-like domain 5 (TB5) of FBN1 and disturbance of the TGF-β signaling pathway have been suggested as the potential mechanisms of AD and GD2 (4).